论文部分内容阅读
随着生物医学领域文献发表量的快速增加,撤稿量也随之增加。本文通过检索PubMed收录的关于中国作者发表文章的撤稿文件,对其中的信息进行提取和统计学分析。结果显示:1)生物医学领域中国作者撤稿在2005年后进入快速增长,平均撤稿时间为16.55月,撤稿主要集中在影响因子为0~3的期刊(58.9%)。2)撤稿原因分别为重复发表或抄袭(40%),科学错误(15%),作者署名或版权问题(8%),伪造数据或怀疑伪造数据(5%)。3)因科学错误、重复发表或抄袭、伪造数据或怀疑伪造数据而撤稿的期刊平均影响因子之间差异无统计学意义(P>0.05)。4)非SCI给出不详撤稿信息的比例明显高于SCI期刊(P<0.05)。撤稿行为是对缺陷科学结论纠错的有效措施,从PubMed收录的对中国作者的撤稿声明分析中可以发现某些中国作者科学失范行为的模式,以及科技期刊编辑部对待撤稿的态度,并可借鉴经验制定出有针对性的措施,促进国内期刊出版环境的净化。
With the rapid increase in the published volume of biomedical literature, the volume of withdrawals also increased. This article extracts and statistically analyzes the information contained in PubMed’s retraction documents on articles published by Chinese authors. The results showed that: 1) the withdrawal of Chinese authors in the field of biomedicine went into rapid growth after 2005, with an average withdrawal time of 16.55 months; the withdrawals mainly focused on journals with influence factors of 0 to 3 (58.9%). 2) Reasons for withdrawal were repeated publication or plagiarism (40%), scientific error (15%), author’s signature or copyright issue (8%), counterfeit data or suspected counterfeiting data (5%) respectively. 3) There was no significant difference between the average impact factors of journals that were withdrawn due to scientific errors, repeated publication or plagiarism, counterfeit data or suspected forged data (P> 0.05). 4) The proportion of non-SCI who provided information of unknown retraction was significantly higher than that of SCI (P <0.05). The retraction behavior is an effective measure to correct the scientific conclusion of the defect. According to the analysis of the retraction statement of Chinese authors published by PubMed, some Chinese authors’ patterns of scientific misconduct can be found out, as well as the editorial department’s treatment of retraction, And learn from experience to develop targeted measures to promote the purification of the domestic publishing environment.